Apimeds Pharmaceuticals US OverviewApimeds Pharmaceuticals US Net Income
Profitability analysis for APUS.
Quarterly Net Income
-$35.06M
↓ 8612.75% YoY
As of Mar 2026
Annual Net Income (TTM)
-$40.66M
↓ 2617.98% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...